Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ultan McDermott

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Communications Biology|April 24, 2024
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancerMatthias Pfeifer, Jonathan S Brammeld, Stacey Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingUltan McDermott, Sreenath V Sharma, Lori Dowell, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Cancer Cell|April 11, 2018
The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian DevilsMaximilian R Stammnitz, Tim H H Coorens, Kevin C Gori, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Nature|April 2, 2015
The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Nature|July 31, 2020
Author Correction: The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Molecular Cancer Therapeutics|April 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancerValentina Cutano, Shanade Dunn, Sungmi Park-Chouinard, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Communications Biology|April 24, 2024
Genome-wide CRISPR screens identify the YAP/TEAD axis as a driver of persister cells in EGFR mutant lung cancerMatthias Pfeifer, Jonathan S Brammeld, Stacey Price, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingUltan McDermott, Sreenath V Sharma, Lori Dowell, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Cancer Cell|April 11, 2018
The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian DevilsMaximilian R Stammnitz, Tim H H Coorens, Kevin C Gori, et al.
Elife|January 19, 2018
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cellsKrishna Kalyan Kolluri, Constantine Alifrangis, Neelam Kumar, et al.
Nature|April 2, 2015
The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Nature Medicine|June 2, 2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFRMiguel Vizoso, Humberto J Ferreira, Paula Lopez-Serra, et al.
Nature|July 31, 2020
Author Correction: The evolutionary history of lethal metastatic prostate cancerGunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Molecular Cancer Therapeutics|April 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancerValentina Cutano, Shanade Dunn, Sungmi Park-Chouinard, et al.
Pageof 12